Abstract:Small-diameter synthetic vascular grafts have high failure rate due to primarily surface thrombogenicity, and effective surface chemical modification is critical to maintain the patency of the grafts. In this study, we engineered a small-diameter, elastic synthetic vascular graft with off-the-shelf availability and antithrombogenic activity. Polycarbonate-urethane (PCU), was electrospun to produce nanofibrous grafts that closely mimicked a native blood vessel in terms of structural and mechanical strength. To overcome the difficulty of adding functional groups to PCU, we explored various surface modification methods, and determined that plasma treatment was the most effective method to modify the graft surface with functional amine groups, which were subsequently employed to conjugate heparin via end-point immobilization. In addition, we confirmed in vitro that the combination of plasma treatment and end-point immobilization of heparin exhibited the highest surface density and correspondingly the highest antithrombogenic activity of heparin molecules. Furthermore, from an in vivo study using a rat common carotid artery anastomosis model, we showed that plasma-heparin grafts had higher patency rate at 2 weeks and 4 weeks compared to plasma-control (untreated) grafts. More importantly, we observed a more complete endothelialization of the lumina] surface with an aligned, well-organized monolayer of endothelial cells, as well as more extensive graft integration in terms of vascularization and cell infiltration from the surrounding tissue. This work demonstrates the feasibility of electrospinning PCU as synthetic elastic material to fabricate nanofibrous vascular grafts, as well as the potential to endow desired functionalization to the graft surface via plasma treatment for the conjugation of heparin or other bioactive molecules.Statement of SignificanceVascular occlusion remains the leading cause of death all over the world, despite advances made in balloon angioplasty and conventional surgical intervention. Currently, autografts are the gold-standard grafts used to treat vascular occlusive disease. However, many patients with vascular occlusive disease do not have autologous vascular graft available. Therefore, there is a widely recognized need for a readily available, functional, small-diameter vascular graft (inner diameter of <6 mm). This work addresses this critical need by developing a method of antithrombogenic modification of synthetic grafts. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Functionalization Of Electrospun Poly(Epsilon-Caprolactone) Scaffold With Heparin And Vascular Endothelial Growth Factors For Potential Application As Vascular Grafts

Electrospun Poly(l-Lactic Acid-Co-ɛ-caprolactone) Fibers Loaded with Heparin and Vascular Endothelial Growth Factor to Improve Blood Compatibility and Endothelial Progenitor Cell Proliferation.

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells

In Vitro Biocompatibility Study of Electrospun Copolymer Ethylene Carbonate-Ɛ-caprolactone and Vascular Endothelial Growth Factor Blended Nanofibrous Scaffolds

Improving Vascular Regeneration Performance of Electrospun Poly(ε-Caprolactone) Vascular Grafts via Synergistic Functionalization with VE-Cadherin/VEGF

End-point Immobilization of Heparin on Plasma-Treated Surface of Electrospun Polycarbonate-Urethane Vascular Graft.

Construction of Bfgf/heparin and Fe3O4 Nanoparticles Functionalized Scaffolds Aiming at Vascular Repair and Magnetic Resonance Imaging Monitoring

Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

Surface modification with hydrophilic and heparin-loaded coating for endothelialization and anticoagulation promotion of vascular scaffold

Engineering the Mechanical and Biological Properties of Nanofibrous Vascular Grafts for in Situ Vascular Tissue Engineering.

Electrospun Polycaprolactone/collagen Nanofibers Cross-Linked with 1-Ethyl-3-(3-dimethylaminopropyl) Carbodiimide/n-Hydroxysuccinimide and Genipin Facilitate Endothelial Cell Regeneration and May Be a Promising Candidate for Vascular Scaffolds.

Surface modification of aligned electrospun poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-based scaffold for binding with fibronectin or collagen in vascular tissue engineering

Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity

Electrospun polyhedral oligomeric silsequioxane-poly(carbonate-urea) urethane for fabrication of hemocompatible small-diameter vascular grafts with angiogenesis capacity

The effect of Substance P/Heparin conjugated PLCL polymer coating of bioinert ePTFE vascular grafts on the recruitment of both ECs and SMCs for accelerated regeneration

Preparation and biocompatibility of electrospun poly(l-lactide-co-ε- caprolactone)/fibrinogen blended nanofibrous scaffolds

Fabrication and Comprehensive Characterization of Biomimetic Extracellular Matrix Electrospun Scaffold for Vascular Tissue Engineering Applications

Customized Vascular Repair Microenvironment: Poly(lactic acid)-Gelatin Nanofibrous Scaffold Decorated with bFGF and Ag@Fe3O4 Core-Shell Nanowires

Hybrid Small-Diameter Vascular Grafts: Anti-expansion Effect of Electrospun Poly Ε-Caprolactone on Heparin-Coated Decellularized Matrices

Electrospun compliant heparinized elastic vascular graft for improving the patency after implantation